FreeGuest Editorial The Write Treatment; when a writing workshop is a part of cancer treatment October 06, 2017Vol.43 No.37By Emily Rubin
Guest Editorial A costly “rebranding” of an old drug comes with a 700% price increase September 29, 2017Vol.43 No.36By Jason Funaro, Henry S. Friedman and Mallika Weant
FreeGuest Editorial How the RACE for Children Act will get drugs to kids with cancer September 08, 2017Vol.43 No.33By Nancy Goodman
Guest Editorial Senate passes a “right to try” bill; Harm to patients comes next August 04, 2017Vol.43 No.31By Kelly McBride Folkers, Lisa Kearns and Alison Bateman-House
FreeGuest Editorial Medical research funding: Why we must keep our foot on the accelerator July 21, 2017Vol.43 No.29By Michael A. Caligiuri
Guest Editorial Impact of Proposed Cuts to NIH Budget:More Than Just About Cancer May 05, 2017Vol.43 No.18By Karen E. Knudsen, Chi Van Dang, Richard I. Fisher, Edward Chu and Dario Altieri
Guest Editorial How not to develop a medical intervention: Learning from the prostate screening debacle April 14, 2017Vol.43 No.15By Otis W. Brawley
FreeGuest Editorial Oregon’s Death with Dignity Act: Learning from 18 years of data on physician-aided dying April 07, 2017Vol.43 No.14By Charles D. Blanke and Lee Ellis
Guest Editorial NCI formulary, moonshot and public-private partnerships January 20, 2017Vol.43 No.03By Howard Fingert
